Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-07 2:52 pm Purchase | 2024-12-27 | 13D | ReShape Lifesciences Inc. RSLS | Dominion Capital LLC | 78,307 9.900% | 78,307 (New Position) | Filing History |
| 2024-09-26 4:45 pm Sale | 2024-09-23 | 13G | ReShape Lifesciences Inc. RSLS | Schneid Yair | 37,407 8.374% | -5,024 (-11.84%) | Filing History |
| 2024-01-16 6:07 pm Purchase | 2024-01-05 | 13G | ReShape Lifesciences Inc. RSLS | Schneid Yair | 42,431 10.525% | 42,431 (New Position) | Filing History |
| 2023-03-17 5:01 pm Purchase | 2023-02-06 | 13D | ReShape Lifesciences Inc. RSLS | Matthew Joseph Nachtrab Revocable Trust 2014 | 2,308 27.700% | 2,308 (New Position) | Filing History |
| 2023-02-15 3:34 pm Purchase | 2023-02-06 | 13D | ReShape Lifesciences Inc. RSLS | FOLEY & LARDNER | 2,308 27.700% | 2,308 (New Position) | Filing History |
| 2023-02-14 1:24 pm Purchase | 2022-12-31 | 13G | ReShape Lifesciences Inc. RSLS | ARMISTICE CAPITAL LLC | 438 4.990% | 438 (New Position) | Filing History |
| 2022-02-14 6:35 pm Purchase | 2021-12-31 | 13G | ReShape Lifesciences Inc. RSLS | ARMISTICE CAPITAL LLC | 681 9.990% | 381 (+126.96%) | Filing History |
| 2022-02-14 06:15 am Purchase | 2010-02-28 | 13G | ReShape Lifesciences Inc. RSLS | INTERWEST PARTNERS X LP | 2 0.000% | 2 (New Position) | Filing History |
| 2021-06-30 06:16 am Unchanged | 2021-06-29 | 13G | ReShape Lifesciences Inc. RSLS | ARMISTICE CAPITAL LLC | 300 9.990% | 0 (Unchanged) | Filing History |
| 2021-06-30 06:10 am Sale | 2021-06-28 | 13D | ReShape Lifesciences Inc. RSLS | ARMISTICE CAPITAL LLC | 300 9.990% | -2,191 (-87.96%) | Filing History |
| 2021-06-25 4:21 pm Purchase | 2021-06-15 | 13D | ReShape Lifesciences Inc. RSLS | ARMISTICE CAPITAL LLC | 2,491 49.800% | 2,491 (New Position) | Filing History |
| 2021-06-21 10:46 am Purchase | 2021-06-16 | 13D | ReShape Lifesciences Inc. RSLS | DOMAIN PARTERS VII L P | 22 13.000% | 22 (New Position) | Filing History |
| 2021-03-15 10:50 am Unchanged | 2021-03-12 | 13D | ReShape Lifesciences Inc. RSLS | DOMAIN PARTERS VII L P | 115 9.800% | 0 (Unchanged) | Filing History |
| 2021-02-16 5:07 pm Unchanged | 2020-12-31 | 13G | ReShape Lifesciences Inc. RSLS | ARMISTICE CAPITAL LLC | 126 14.200% | 0 (Unchanged) | Filing History |
| 2021-02-12 3:32 pm Sale | 2020-12-31 | 13G | ReShape Lifesciences Inc. RSLS | MORGAN STANLEY MS | 0 0.000% | -52 (-99.97%) | Filing History |
| 2021-02-12 06:09 am Unchanged | 2010-02-28 | 13G | ReShape Lifesciences Inc. RSLS | INTERWEST PARTNERS X LP | 46 5.100% | 0 (Unchanged) | Filing History |
| 2021-01-08 09:49 am Sale | 2020-12-31 | 13G | ReShape Lifesciences Inc. RSLS | SABBY MANAGEMENT, LLC | 45 11.000% | -21 (-32.02%) | Filing History |
| 2020-11-10 5:14 pm Purchase | 2020-10-31 | 13G | ReShape Lifesciences Inc. RSLS | ARMISTICE CAPITAL LLC | 126 14.200% | 46 (+57.21%) | Filing History |
| 2020-10-23 4:30 pm Unchanged | 2020-10-23 | 13D | ReShape Lifesciences Inc. RSLS | DOMAIN PARTERS VII L P | 115 12.600% | 0 (Unchanged) | Filing History |
| 2020-09-25 4:33 pm Purchase | 2020-09-17 | 13G | ReShape Lifesciences Inc. RSLS | ARMISTICE CAPITAL LLC | 80 9.000% | 80 (New Position) | Filing History |